Abbott Laboratories (ABT.N)
105.11USD
30 Oct 2020
$0.11 (+0.10%)
$105.00
$104.87
$105.55
$103.13
1,469,069
1,345,898
$114.19
$61.62
About
Buy/Sell
Overall
| Beta: | 1.57 |
| Market Cap(Mil.): | $95,559.38 |
| Shares Outstanding(Mil.): | 1,737.44 |
| Dividend: | 0.26 |
| Yield (%): | 1.93 |
UPDATE 1-Boston Scientific reports loss as COVID-19 slams demand for medical devices
Oct 28 Boston Scientific Corp swung to a loss in the third quarter from profit a year ago, as demand for its medical devices was hurt by the ongoing COVID-19 pandemic.
EU weighs buying Roche, Abbott rapid COVID tests amid limited supplies
BRUSSELS/ZURICH, Oct 27 European countries are looking at buying millions of COVID-19 rapid tests mostly from Roche and Abbott, an EU document shows, as global production of the tests is stretched by a surge in infections.
European cities plead for more flu shots as winter looms, pandemic rages
WARSAW/MILAN/VIENNA A surge in demand for vaccines to ward off the winter flu has led to shortages in some European cities, raising the risk of a potentially lethal "twindemic" as COVID-19 cases soar.
UPDATE 1-European cities plead for more flu shots as winter looms, pandemic rages
WARSAW/MILAN/VIENNA, Oct 22 A surge in demand for vaccines to ward off the winter flu has led to shortages in some European cities, raising the risk of a potentially lethal "twindemic" as COVID-19 cases soar.
Quest raises profit forecast as COVID-19 tests demand to jump
Quest Diagnostics Inc raised its full-year earnings expectations on Thursday after a strong quarterly beat and forecast robust demand for COVID-19 tests during the fall season and into 2021.
UPDATE 3-Quest raises profit forecast as COVID-19 tests demand to jump
Oct 22 Quest Diagnostics Inc raised its full-year earnings expectations on Thursday after a strong quarterly beat and forecast robust demand for COVID-19 tests during the fall season and into 2021.
European cities plead for more flu shots as winter looms, pandemic rages
WARSAW/MILAN/VIENNA, Oct 22 A surge in demand for vaccines to ward off the winter flu has led to shortages in some European cities, raising the risk of a potentially lethal "twindemic" as COVID-19 cases spike.
Breakingviews - Corona Capital: U.S. tests, UK loans, Man U groans
NEW YORK/LONDON/HONG KONG (Reuters Breakingviews) - Corona Capital is a column updated throughout the day by Breakingviews columnists around the world with short, sharp pandemic-related insights.
Abbott says COVID-19 test demand to grow in 2021
Abbott Laboratories said it expects demand for its COVID-19 tests to grow in 2021 even if a vaccine is developed and for the business to eventually stabilize into a lucrative new franchise.
Märkte
- U.S.
- Europa
- Asien
- Branchen
| DOW | 26,501.60 |
-157.51 |
-0.59% |
| S&P 500 | 3,269.96 |
-40.15 |
-1.21% |
| NASDAQ | 10,911.59 |
-274.00 |
-2.45% |
| TR US Index | 289.33 |
-4.05 |
-1.38% |
Rohstoffe
| Gold | 1,876.10 | +10.50 | +0.56% |
| Oil | 35.72 | -0.45 | -1.24% |
| Corn | 397.50 | -1.00 | -0.25% |
Rohstoffe
| Gold | 1,876.10 | +10.50 | +0.56% |
| Oil | 35.72 | -0.45 | -1.24% |
| Corn | 397.50 | -1.00 | -0.25% |
Rohstoffe
| Gold | 1,876.10 | +10.50 | +0.56% |
| Oil | 35.72 | -0.45 | -1.24% |
| Corn | 397.50 | -1.00 | -0.25% |
Branchenüberblick
| Energie |
-0.22%
|
| Rohstoffe |
-0.82%
|
| Industrie |
-2.33%
|
| Konjunktur abhängige Waren & Dienstleistungen |
-0.51%
|
| Konjunktur unabhängige Waren & Dienstleistungen |
+0.06%
|
| Finanzindustrie |
-0.79%
|
| Pharma |
-2.12%
|
| Technologie |
+0.00%
|
Nachrichten aus der Wirtschaft
Trump will neues Hilfspaket sofort nach Wahl - Mehrheitsführer im Senat 2021
Washington Bei den Verhandlungen über ein neues Corona-Hilfspaket in den USA haben Präsident Donald Trump und seine Republikaner im Senat unterschiedliche Zeiträume vorgegeben.